Reported 25 days ago
Canadian generic drug manufacturer Apotex Inc. is gearing up for a potential initial public offering (IPO) next year, enlisting RBC Capital Markets, Jefferies Financial Group, and TD Securities as advisers. Although specific details regarding timing and size are yet to be finalized, this move follows Apotex's recent acquisition by private equity firm SK Capital Partners and its strategic purchase of Searchlight Pharma Inc.
Source: YAHOO